Shenzhen Moshen Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shenzhen Moshen Technology Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include JSTMA, AZUJOS, and HOIBUN. The owner is based in Longgang Dist,Shenzhen.
201, BLK 5, Gongxiaoshe Industrial Park,
Fenghuang Community, Pinghu St.
Longgang Dist,Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Moshen Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen Moshen Technology Co., Ltd. have?
Shenzhen Moshen Technology Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Shenzhen Moshen Technology Co., Ltd. file in?
Shenzhen Moshen Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Shenzhen Moshen Technology Co., Ltd.'s most well-known trademarks?
Shenzhen Moshen Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as JSTMA, AZUJOS, and HOIBUN. These are among 3 currently registered trademarks in the portfolio.
What is Shenzhen Moshen Technology Co., Ltd.'s trademark registration success rate?
Shenzhen Moshen Technology Co., Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.